Home > Annual Financials > KIMIA BIOSCIENCES

KIMIA BIOSCIENCES Financial Statement Analysis
[BOM: 530313]

The Revenues of KIMIA BIOSCIENCES have decreased by -3.39% YoY .
The Earnings Per Share (EPS) of KIMIA BIOSCIENCES has decreased by -22.66 % YoY.
COMMUNITY POLL
for KIMIA BIOSCIENCES
Please provide your vote to see the results

KIMIA BIOSCIENCES Last 5 Annual Financial Results
[BOM: 530313]

StandaloneMar2026
Mar2025
Mar2024
Mar2023
Mar2022
Revenues ₹115 Cr₹119 Cr₹105 Cr₹129 Cr₹125 Cr
Expenses ₹101 Cr₹99 Cr₹105 Cr₹134 Cr₹124 Cr
Operating Profit (Excl OI) ₹14 Cr₹20 Cr₹-0.48 Cr₹-5.09 Cr₹0.63 Cr
Other Income ₹1.62 Cr₹1.32 Cr₹1.64 Cr₹1.33 Cr₹0.93 Cr
Interest ₹3.52 Cr₹4.56 Cr₹5.05 Cr₹4.25 Cr₹3.64 Cr
Depreciation ₹3.91 Cr₹3.38 Cr₹3.29 Cr₹3.33 Cr₹2.94 Cr
Profit Before Tax ₹8.46 Cr₹14 Cr₹-7.18 Cr₹-12 Cr₹-5.02 Cr
Profit After Tax ₹7.43 Cr₹9.61 Cr₹-5.31 Cr₹-9.35 Cr₹-3.70 Cr
Earnings Per Share (Rs)₹1.57₹2.03₹-1.12₹-1.98₹-0.78
PAT Margin (%)6.478.08-5.06-7.28-2.96
ROE(%)53.70186.70-183.25-91.91-22.22
ROCE(%)25.2442.18-4.18-14.30-2.32
Total Debt/Equity(x)1.953.27131.129.692.73

Key Financials

Market Cap : ₹ 158.4 Cr
Revenue (TTM) : ₹ 104.8 Cr
Net Profit(TTM) : ₹ 8.6 Cr
EPS (TTM) : ₹ 1.8
P/E (TTM) : 18.5

Industry Peers & Returns1W1M1Y
KIMIA BIOSCIENCES 11.3% -0.2% 7.8%
SUN PHARMACEUTICAL INDUSTRIES -2% 6% 9.6%
DIVIS LABORATORIES -4% 22.9% 75.8%
TORRENT PHARMACEUTICALS -1.8% 1.8% 21.9%
CIPLA -0.9% 4.5% -8%
DR REDDYS LABORATORIES -0.4% 13.1% 13.7%
MANKIND PHARMA -1.4% 11.5% 19.5%
LUPIN -2% 0.7% 0.2%
ZYDUS LIFESCIENCES -2% 4.2% 27%


KIMIA BIOSCIENCES Revenues
[BOM: 530313]

Y-o-Y

-3.39 %

5 Yr CAGR

-2.07 %

Years Revenues % Change
Mar2026 ₹115 Cr
-3.39
Mar2025 ₹119 Cr
13.39
Mar2024 ₹105 Cr
-18.39
Mar2023 ₹129 Cr
2.89
Mar2022 ₹125 Cr -


KIMIA BIOSCIENCES Operating Profit
[BOM: 530313]

Y-o-Y

-29.55 %

5 Yr CAGR

118.06 %

Years Operating Profit % Change
Mar2026 ₹14 Cr
-29.55
Mar2025 ₹20 Cr
Positive
Mar2024 ₹-0.48 Cr
Negative
Mar2023 ₹-5.09 Cr
Negative
Mar2022 ₹0.63 Cr -

Operating Margins
Y-o-Y

-27.07 %

5 Yr CAGR

122.15 %

Years Operating Margin% % Change
Mar2026 12.42%
-27.07
Mar2025 17.03%
Positive
Mar2024 -0.46%
Negative
Mar2023 -3.96%
Negative
Mar2022 0.51% -

KIMIA BIOSCIENCES Profit After Tax
[BOM: 530313]

Y-o-Y

-22.66 %

5 Yr CAGR

Positive

Years Profit After Tax % Change
Mar2026 ₹7.43 Cr
-22.66
Mar2025 ₹9.61 Cr
Positive
Mar2024 ₹-5.31 Cr
Negative
Mar2023 ₹-9.35 Cr
Negative
Mar2022 ₹-3.70 Cr -

PAT Margins
Y-o-Y

-19.93 %

5 Yr CAGR

Positive

Years PAT Margin(%) % Change
Mar2026 6.47 %
-19.93
Mar2025 8.08 %
Positive
Mar2024 -5.06 %
Negative
Mar2023 -7.28 %
Negative
Mar2022 -2.96 % -

KIMIA BIOSCIENCES Earnings Per Share (EPS)
[BOM: 530313]

Y-o-Y

-22.66 %

5 Yr CAGR

Positive

Years EPS % Change
Mar2026 ₹1.57
-22.66
Mar2025 ₹2.03
Positive
Mar2024 ₹-1.12
Negative
Mar2023 ₹-1.98
Negative
Mar2022 ₹-0.78 -

KIMIA BIOSCIENCES Return on Capital Employed (ROCE)
[BOM: 530313]

Y-o-Y

-40.16 %

5 Yr CAGR

Positive

Years ROCE % Change
Mar2026 25.24%
-40.16
Mar2025 42.18%
Positive
Mar2024 -4.18%
Negative
Mar2023 -14.3%
Negative
Mar2022 -2.32% -

KIMIA BIOSCIENCES Share Price vs Sensex

Current Share Price : ₹33.5
Current MarketCap: ₹ 158.4 Cr
Updated EOD on :Nov 16,2026

Share Price Returns(%) 1 Week 1 Month 1 Year
KIMIA BIOSCIENCES

11.3%

-0.2%

7.8%

SENSEX

1.4%

12.8%

-1.7%

KIMIA BIOSCIENCES related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about KIMIA BIOSCIENCES Financials


How the annual revenues of KIMIA BIOSCIENCES have changed ?

The Revenues of KIMIA BIOSCIENCES have decreased by -3.39% YoY .

How the Earnings per Share (EPS) of KIMIA BIOSCIENCES have changed?

The Earnings Per Share (EPS) of KIMIA BIOSCIENCES has decreased by -22.66 % YoY .